Issue Code: TAR
2,629
639
424
2025--2026
10 activities
BALLARD PARTNERS
179 activities
ELEVATE GOVERNMENT AFFAIRS, LLC
68 activities
BROWNSTEIN HYATT FARBER SCHRECK, LLP
64 activities
HANCE SCARBOROUGH
58 activities
CHECKMATE GOVERNMENT RELATIONS
44 activities
CLARK HILL PUBLIC STRATEGIES LLC
44 activities
CAPITOLINE CONSULTING, LLC
38 activities
FORBES-TATE
37 activities
BGR GOVERNMENT AFFAIRS
32 activities
MILLER STRATEGIES, LLC
30 activities
HOUSE OF REPRESENTATIVES
1,839 mentionsSENATE
1,821 mentionsCommerce, Dept of (DOC)
752 mentionsU.S. Trade Representative (USTR)
707 mentionsWhite House Office
424 mentionsExecutive Office of the President (EOP)
188 mentionsTreasury, Dept of
185 mentionsAgriculture, Dept of (USDA)
83 mentionsState, Dept of (DOS)
67 mentionsEnergy, Dept of
64 mentionsNATIONAL ASSOCIATION OF MANUFACTURERS
via NATIONAL ASSOCIATION OF MANUFACTURERS
301 investigations and tariffs First Sale bill Agreements on Reciprocal Trade IEEPA tariffs Pharmaceutical tariffs Sec 232 steel and aluminum tariffs and derivatives USMCA
NATIONAL ASSOCIATION OF MANUFACTURERS
via NATIONAL ASSOCIATION OF MANUFACTURERS
Miscellaneous Tariff Bill Section 301 Tariffs
NATIONAL ASSOCIATION OF MANUFACTURERS
via NATIONAL ASSOCIATION OF MANUFACTURERS
Miscellaneous Tariff Bill Section 301 Tariffs
NATIONAL ASSOCIATION OF MANUFACTURERS
via NATIONAL ASSOCIATION OF MANUFACTURERS
Miscellaneous Tariff Bill Section 301 Tariffs
CLEANSPARK, INC
via CLEANSPARK, INC
tariff issues related to imported goods
APPLIED MATERIALS, INC.
via BROWNSTEIN HYATT FARBER SCHRECK, LLP
Issues surrounding Section 302 and 232 tariffs; Advocacy surrounding semiconductor policies affecting U.S. competitiveness; Employment-based visa programs; Workforce development initiatives; National security concerns as it relates to supply chain resiliency; Energy and environmental issues affecting manufacturing including rare earth minerals .
RAI SERVICES COMPANY (FKA REYNOLDS AMERICAN, INC.)
via CAPITOL NETWORK LLC(FKA MR. DAVID DISTEFANO)
Duty Drawback
AMERICAN NITRILE
via CAPITOL NETWORK LLC(FKA MR. DAVID DISTEFANO)
Tariff Offset Proposals
ASTRAZENECA PHARMACEUTICALS LP
via ASTRAZENECA PHARMACEUTICALS LP
Tax proposals building on One Big Beautiful Bill Act law and implementation (R&D expensing, BEAT, FDII, Corporate Alternative Minimum Tax) HR 591 - Defending American Jobs and Investment Act HR 1414 - Camerons Law, to restore orphan drug research tax credit HR 1911 - To amend the Internal Revenue Code of 1986 to provide that certain payments to foreign related parties subject to sufficient foreign tax are not treated as base erosion payments HR 1990 - American Innovation and R&D Competitiveness Act of 2025 S.1605 - International Competition for American Jobs Act S.1639 - American Innovation and Jobs Act S.3841 - Last Sale Valuation Act of 2026 Issues related to a Most Favored Nations policy in Medicare and Medicaid Issues related to the renewable energy tax credits and other energy credits included in the Inflation Reduction Act Most Favored Nations and pharmaceutical R&D innovation Most Favored Nation drug pricing proposals Pharmaceutical investment and pricing issues in ex-US countries US trade tools (investigations, tariffs, trade agreements, congressional oversight, rules of origin, CBP enforcement, investment screening) US-Mexico-Canada trade agreement (USMCA)
MOLNLYCKE HEALTH CARE US, LLC
via MOLNLYCKE HEALTH CARE US, LLC
Lobbying around MedTech exemption from tariff implementation under IEEPA and 232 investigations.